While reporting financial results for the third quarter on Tuesday, Cracker Barrel Old Country Store, Inc. (CBRL) said it anticipates revenue growth of 1 to 3 percent for the fourth quarter.
On average, nine analysts polled by Thomson Reuters expect the company to report net sales growth of 6.9 percent...
Cracker Barrel Old Country Store, Inc. (CBRL) reported earnings for third quarter that decreased from last year and missed the Street estimates.
The company's bottom line totaled $13.97 million, or $0.63 per share. This compares with $27.52 million, or $1.19 per share, in last year's third quarter.
Excluding...
Fashion retailer Chico's Fas Inc. (CHS) on Tuesday reported net income for the first quarter of $39.91 million or $0.32 per share, higher than $34.93 million or $0.28 per share in the year-ago quarter.
Total net sales for the quarter decreased 1.1 percent to $534.74 million from $540.92 million in...
Ciena Corp. (CIEN) revealed a profit for its second quarter that increased from last year and beat the Street estimates.
The company's earnings came in at $57.654 million, or $0.38 per share. This compares with $38.922 million, or $0.25 per share, in last year's second quarter.
Excluding items,...
Below are the earnings highlights for The J. M. Smucker Company (SJM):
Earnings: -$600.7 million in Q4 vs. $202.1 million in the same period last year.
EPS: -$5.69 in Q4 vs. $1.87 in the same period last year.
Excluding items, The J. M. Smucker Company reported adjusted earnings of $279.7 million...
Science Applications International Corporation (SAIC) announced earnings for its first quarter that increased from last year and beat the Street estimates.
The company's earnings came in at $98 million, or $1.79 per share. This compares with $73 million, or $1.29 per share, in last year's first...
Software solutions company EPAM (EPAM) on Monday announced that it is reducing its second quarter and full year 2023 outlook due to further deterioration in the near-term demand environment.
For the second quarter of the year, the company has revised down its guidance for earnings per share to be...
AstraZeneca PLC (AZN.L, AZN) announced positive results from interim analysis of DUO-O Phase III trial showed that LYNPARZA and IMFINZI combination reduced risk of disease progression or death by 37% vs. chemotherapy and bevacizumab in patients with advanced high-grade epithelial ovarian cancer without...